Mammalian Plasma Proteome Quantitative Analysis Service

Plasma contains a complex mixture of circulating proteins associated with physiological states, biological processes, and responses to experimental conditions. Quantitative plasma proteomics enables researchers to compare protein abundance patterns between biological groups and identify candidate proteins associated with specific research questions.

A major challenge in plasma proteomics is the wide dynamic range of protein concentrations. Highly abundant proteins can dominate the overall protein signal and reduce the detection of lower-abundance proteins. Therefore, sample preparation and analytical strategies need to be selected according to the required proteome depth and study objectives.

Service at MtoZ Biolabs

MtoZ Biolabs provides the Mammalian Plasma Proteome Quantitative Analysis Service using high-resolution LC-MS/MS platforms for plasma protein profiling and quantitative comparison.

The service combines plasma-specific sample preparation, quantitative proteomics strategies, and targeted follow-up options to support different research objectives.

1. Plasma Sample Preparation Optimization

Due to the complexity of plasma samples, preparation strategies are optimized according to sample availability and required analytical depth. High-abundance protein depletion can be incorporated when deeper proteome coverage is required, while non-depleted workflows may also be considered when they better match the research objectives and sample characteristics.

2. Plasma Proteome Profiling and Quantification

LC-MS/MS-based proteomics workflows are applied to identify and quantify plasma proteins across different biological conditions.

Label-free or TMT-based quantitative strategies can be selected according to sample number, comparison design, and analytical requirements. DDA or DIA acquisition can be applied as appropriate within the selected workflow to support comprehensive and consistent protein quantification.

3. Targeted Protein Follow-Up

Candidate proteins identified through discovery proteomics can be further evaluated using targeted mass spectrometry approaches, including PRM or MRM.

When absolute quantification is required, targeted assays can incorporate isotope-labeled internal standards and calibration strategies.

Analysis Workflow

1. Study Design and Sample Evaluation

Sample source, biological groups, replicate design, available sample amount, and analytical objectives are reviewed to determine an appropriate workflow.

2. Plasma Sample Preparation

Plasma samples undergo compatible preparation procedures according to the selected analytical strategy. Optional high-abundance protein depletion can be included when required.

3. Protein Digestion and LC-MS/MS Analysis

Proteins are enzymatically digested into peptides and analyzed using the selected LC-MS/MS acquisition strategy.

4. Protein Identification and Quantification

Mass spectrometry data are processed to generate protein identification and quantitative datasets.

5. Comparative Data Analysis

Where supported by the study design, quantitative results can be evaluated through differential protein analysis and downstream biological interpretation.

Applications

The Mammalian Plasma Proteome Quantitative Analysis Service can support:

• comparison of plasma protein profiles between experimental groups; 
• biomarker discovery research; 
• investigation of biological responses to treatment or perturbation; 
• plasma proteome analysis in animal models; 
• identification of candidate proteins for targeted validation; 
• comparative studies requiring large-scale protein quantification. 

Why Choose MtoZ Biolabs?

1. Advanced Mass Spectrometry Platforms

High-resolution LC-MS/MS platforms support comprehensive plasma protein profiling and quantitative analysis.

2. Plasma-Focused Sample Preparation

Optimized preparation strategies help address plasma complexity and improve analytical depth when required.

3. Multiple Quantitative Workflows

Label-free and TMT-based quantification support global protein comparison, with PRM/MRM available for targeted follow-up analysis.

4. Integrated Data Analysis

Statistical analysis, functional annotation, enrichment analysis, and pathway interpretation support biological understanding of quantitative proteomics results.

5. Transparent Pricing

The analytical scope, workflow design, and deliverables are clearly defined before quotation, with no additional charges within the confirmed service scope.

Sample Submission Suggestions

1. Sample requirements vary depending on sample type, available volume, and analytical objectives.

2. EDTA or citrate plasma is generally preferred for MS-based proteomics when possible. The same anticoagulant and collection protocol should be used across samples within a study to minimize pre-analytical variation.

3. Samples should be stored at -80°C and shipped on dry ice while minimizing repeated freeze-thaw cycles.

4. Please contact MtoZ Biolabs with your plasma source, sample number, available volume, and study design before submission so that the appropriate workflow can be confirmed.

Deliverables

Depending on the study design and selected workflow, deliverables may include:

• Detailed description of experimental steps and methods
• Mass spectrometry parameters and spectra
• Raw data files (RAW/mzML format)
• Protein quantification result tables
• Differential protein analysis and statistics
• Functional annotation and pathway analysis charts
• Comprehensive interpretation with visualized data presentation

FAQ

Q1. Is high-abundance protein depletion required for plasma proteomics?

Not in every study. Depletion can improve access to lower-abundance proteins but may also introduce additional processing variability or co-depletion of associated proteins. The appropriate strategy depends on sample availability, required proteome depth, and research objectives.

Q2. Which quantitative strategy is suitable for mammalian plasma proteomics?

Label-free or TMT-based quantification can be selected according to sample number and study design. DDA or DIA acquisition may be applied as appropriate within the overall workflow. PRM or MRM is more suitable when predefined proteins require targeted follow-up quantification.

Q3. What plasma anticoagulant is recommended?

EDTA or citrate plasma is generally preferred for MS-based proteomics when possible. The same anticoagulant and collection protocol should be maintained across samples within a study. If another anticoagulant was used, please provide this information before submission.

Contact Us

MtoZ Biolabs provides mammalian plasma proteome quantitative analysis services for researchers investigating plasma protein changes across biological conditions.

Contact our technical team with your sample information and study objectives to discuss the most suitable LC-MS/MS-based proteomics strategy for your project.